Cancer therapy with an oncolytic virus combined with a checkpoint inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11964015
APP PUB NO 20210228714A1
SERIAL NO

17226199

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns a pharmaceutical composition where a checkpoint inhibitor is combined with an oncolytic virus and the use of said combination for the treatment of cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
DEUTSCHES KREBSFORSCHUNGSZENTRUMIM NEUENHEIMER FELD 280 HEIDELBERG 69120

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Angelova, Assia Heidelberg, DE 4 10
Dahm, Michael Munich, DE 8 44
Jager, Dirk Mainz-Kostheim, DE 16 97
Leuchs, Barbara Heidelberg, DE 19 15
Marchini, Antonio Heidelberg, DE 15 9
Rommelaere, Jean Heidelberg, DE 48 78
Wick, Wolfgang Heidelberg, DE 31 127

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Oct 23, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 23, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 23, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00